Parents of children with developmental, behavioural and mental health disorders are
increasingly asking whether medicinal cannabis might be a therapeutic option for their child …

It has been several years since highly purified cannabidiol (CBD) was registered as a
medication that can be used in children of at least 2 years of age to treat different types of …

Aim This study aims to analyze the health‐related quality of life (HRQoL) and safety
outcomes in attention‐deficit/hyperactivity disorder (ADHD) patients treated with cannabis …

Background Up to now, it is unclear whether different medicinal cannabis (MC) strains are
differently efficacious across different medical conditions. In this study, the effectiveness of …

Attention-deficit/hyperactivity disorder (ADHD) is a psychiatric condition well recognized in
the pediatric population that can persist into adulthood. The vast majority of patients with …

Results Higher scores on conduct problems and lower on peer problems at 14 years-old (n=
318) predicted a greater likelihood of transitioning to cannabis use within 5 years. At 19 …

There is a paucity of research, especially in the UK, that investigates individual differences in
both medical and recreational cannabis users. A cross-sectional survey study design was …

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder
in children and adults. In the substance use disorders (SUDs) population, ADHD prevalence …

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition that is
estimated to affect 5% of children and adolescents worldwide. The core manifestations of …

La investigación aborda la necesidad de mejorar el diagnóstico y tratamiento del Trastorno
por Déficit de Atención e Hiperactividad (TDAH) en adultos. Se propone utilizar técnicas de …